/Companies

AveXis

Bannockburn, US · Founded 2012 · 6 known investors

Find your way into AveXis

Sign up to see every warm intro you have to AveXis

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AveXis team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

New gene therapy treatments for people with serious, rare diseases. (NASDAQ: BOLD) (Acquired by Astellas)

Founders & leadership

AveXis was founded in 2012 by Brian Kaspar.

BK
Brian KasparFounder
JL
James L'ItalienExecutive
AF
Andrew F. KnudtenExecutive
SN
Sukumar NagendranExecutive
TD
Thomas DeeExecutive
SN
Sean NolanExecutive

Board

PMPaul Manning
Paul ManningBoard directorChairman and CEO at PBM Capital
BK
Bong KohBoard director
CN
Carole NuechterlainBoard director
JLJonathan Leff
Jonathan LeffBoard directorExecutive Partner, Private Equity at Sofinnova Ventures
JD
John D. HarkeyBoard director

Investors · 6

Funding

SEC filings, press & company announcements

$65M disclosed across 1 of 2 rounds · 2015–2020

▶$65MraisedSep 2015 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James L'ItalienExecutive Officer
  • Andrew F. KnudtenExecutive Officer
  • Paul ManningDirector
  • Sukumar NagendranExecutive Officer
  • Bong KohDirector
  • Thomas DeeExecutive Officer
  • Sean NolanExecutive Officer, Director
  • Carole NuechterlainDirector
  • Brian KasparExecutive Officer, Director
  • Jonathan LeffDirector
  • John D. HarkeyDirector
Offering amount
$65M
Amount sold
$65M
First sale
Sep 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does AveXis do?
New gene therapy treatments for people with serious, rare diseases. (NASDAQ: BOLD) (Acquired by Astellas)
Who founded AveXis?
AveXis was founded by Brian Kaspar in 2012.
Who are AveXis's investors?
AveXis's investors include Foresite Capital, PBM Capital, RA Capital, Sofinnova Ventures, Deerfield Management Company, Roche Venture Fund.
How much funding has AveXis raised?
AveXis has disclosed $65M raised across 1 of its 2 known rounds.
Where is AveXis headquartered?
AveXis is headquartered in Bannockburn, US.